Cargando…

Multidisciplinary Therapy in Men with Newly Diagnosed Oligometastatic Prostate Cancer

PURPOSE: To assess the use of aggressive local therapy with systemic therapy for patients with oligometastatic prostate cancer. PATIENTS AND METHODS: Patients with oligometastatic prostate cancer received systemic therapy centered on androgen deprivation therapy (ADT). After six months or more of AD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Watanabe, Kazuhiro, Kawaguchi, Gen, Ikeda, Yohei, Hara, Noboru, Nishiyama, Tsutomu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Case Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364336/ https://www.ncbi.nlm.nih.gov/pubmed/34408989 http://dx.doi.org/10.2147/RRU.S320433

Ejemplares similares

Multidisciplinary total eradication therapy (TET) in men with newly diagnosed oligometastatic prostate cancer
por: Reyes, D. K., et al.
Publicado: (2020)

Prostate-specific antigen doubling time following radium-223 treatment as a predictor of the clinical course in patients with metastatic castration-resistant prostate cancer
por: Kawaguchi, Gen, et al.
Publicado: (2023)

A Pilot Trial of Pembrolizumab plus Prostatic Cryotherapy for Men with Newly Diagnosed Oligometastatic Hormone-Sensitive Prostate Cancer
por: Ross, Ashley E., et al.
Publicado: (2019)

Successful Response of Pembrolizumab Rechallenge after Radiotherapy for a Patient with Bladder Cancer of Nonresponse of Pembrolizumab First Challenge
por: Ikeda, Taro, et al.
Publicado: (2021)

Clear Cell Adenocarcinoma of the Ureter Similar to Clear Cell Renal Cell Carcinoma Histology
por: Watanabe, Kazuhiro, et al.
Publicado: (2021)

How to handle oligometastatic disease in nonsmall cell lung cancer
por: Eichhorn, Florian, et al.
Publicado: (2021)

A case of cabozantinib therapy leading to complete remission for massive intra-intestinal bleeding and worsening metastatic sites following nivolumab and ipilimumab therapy
por: Ishida, Kyohei, et al.
Publicado: (2023)

Complete remission following pembrolizumab therapy for a patient with nephroureterectomy positive-margin carcinoma in situ and bladder cancer unresponsive to Bacille Calmette–Guérin therapy
por: Nakamura, Ryohta, et al.
Publicado: (2023)

Treatment of newly diagnosed sarcoid-associated pulmonary hypertension with ambrisentan and tadalafil combination therapy
por: Abston, Eric, et al.
Publicado: (2020)

Superselective intra-arterial melphalan therapy for newly diagnosed and refractory retinoblastoma: results from a single institution
por: Thampi, Sheila, et al.
Publicado: (2013)

Long-Term Survival with Ibrutinib Therapy in Elderly Patients with Newly Diagnosed Primary Central Nervous System Lymphoma
por: Kuhlman, Justin J, et al.
Publicado: (2022)

Oligometastatic Prostate Cancer
por: Stevens, Daniel J., et al.
Publicado: (2016)

Oligometastatic prostate cancer: Metastases-directed therapy?
por: Van Poppel, Hein, et al.
Publicado: (2016)

Emergence of undifferentiated urothelial carcinoma after pembrolizumab treatment for patient with invasive urothelial bladder cancer: A case report
por: Hasegawa, Moto, et al.
Publicado: (2020)

Cost-effectiveness of Prostate Radiation Therapy for Men With Newly Diagnosed Low-Burden Metastatic Prostate Cancer
por: Lester-Coll, Nataniel H., et al.
Publicado: (2021)

Laparoscopic Nephroureterectomy with Heminephrectomy for Urothelial Carcinoma of the Upper Renal Pelvis on the Left Side of the Horseshoe Kidney
por: Ikeda, Taro, et al.
Publicado: (2022)

Primary lung cancer treatable with radical resection after complete remission with pembrolizumab therapy following gemcitabine and carboplatin chemotherapy for multiple metastases of bladder cancer
por: Nakamura, Ryohta, et al.
Publicado: (2022)

The role of hormone therapy and chemotherapy in oligometastatic prostate cancer
por: Miura, Yuji, et al.
Publicado: (2019)

Recognition of and treatment recommendations for oligometastatic disease in multidisciplinary tumor boards
por: Christ, Sebastian M., et al.
Publicado: (2022)

Prediction of pathological and oncological outcomes based on extended prostate biopsy results in patients with prostate cancer receiving radical prostatectomy: a single institution study
por: Ishizaki, Fumio, et al.
Publicado: (2012)

Stereotactic body radiation therapy in the treatment of oligometastatic prostate cancer
por: Ahmed, Kamran A., et al.
Publicado: (2013)

Multimodal therapy in oligometastatic prostate cancer: A glimpse into the future?
por: Knipper, Sophie, et al.
Publicado: (2021)

Outcomes of metastasis-directed therapy of bone oligometastatic prostate cancer
por: Rogowski, Paul, et al.
Publicado: (2021)

Mediastinal tumours and pseudo-tumours: a comprehensive review with emphasis on multidisciplinary approach
por: Ghigna, Maria-Rosa, et al.
Publicado: (2021)

Role of surgery in oligometastatic prostate cancer
por: Jenjitranant, Pocharapong, et al.
Publicado: (2019)

Brachytherapy for oligometastatic prostate cancer to the penis
por: Martz, Nicolas, et al.
Publicado: (2021)

IgG4-related Periarteritis Successfully Diagnosed by an Alternative Prostate Biopsy
por: Koda, Ryo, et al.
Publicado: (2019)

Primary malignant melanoma of the female urethra: A case report
por: Watanabe, Kazuhiro, et al.
Publicado: (2020)

A randomized phase II study of letrozole vs. observation in patients with newly diagnosed uterine leiomyosarcoma (uLMS)
por: Slomovitz, Brian M., et al.
Publicado: (2018)

Simultaneous Laparoscopic Surgery for Bladder Diverticulum and Urachal Remnant: A Case Report
por: Murata, Masaki, et al.
Publicado: (2019)

Retroperitoneal fibrosis associated with IgG4-related disease diagnosed by prostate biopsy developed with acute post-renal renal failure: A case report
por: Inui, Kohei, et al.
Publicado: (2017)

Phase II study of helical tomotherapy in the multidisciplinary treatment of oligometastatic colorectal cancer
por: Engels, Benedikt, et al.
Publicado: (2012)

Oligometastatic prostate cancer: Reality or figment of imagination?
por: Foster, Corey C., et al.
Publicado: (2018)

Imaging modalities in synchronous oligometastatic prostate cancer
por: Futterer, Jurgen J., et al.
Publicado: (2018)

Stereotactic ablative radiotherapy for oligometastatic prostate cancer
por: Gallizia, Elena, et al.
Publicado: (2022)

Oligometastatic carcinoma prostate – An overview of the last decade
por: Shah, Milap J, et al.
Publicado: (2023)

A phase II randomized trial of metastasis-directed therapy with alpha emitter radium-223 in men with oligometastatic castration-resistant prostate cancer (MEDAL)
por: Yoshida, Soichiro, et al.
Publicado: (2023)

Multidisciplinary evaluation of interstitial lung diseases: current insights: Number 1 in the Series “Radiology” Edited by Nicola Sverzellati and Sujal Desai
por: Walsh, Simon L.F.
Publicado: (2017)

Urothelial carcinoma with sarcomatoid/osteosarcoma variant of the bladder: A case report
por: Murata, Masaki, et al.
Publicado: (2020)

Radiation Therapy in the Definitive Management of Oligometastatic Prostate Cancer: The Johns Hopkins Experience
por: Deek, Matthew P., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bg9197hvdkrjf4rbqhjf7c07at